Yin Zhuoran, Valkenburg Femke, Hornix Betty E, Mantingh-Otter Ietje, Zhou Xingdong, Mari Muriel, Reggiori Fulvio, Van Dam Debby, Eggen Bart J L, De Deyn Peter P, Boddeke Erik
Department of Neuroscience, Section Medical Physiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Department of Medical Ultrasound, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
J Alzheimers Dis. 2017;60(s1):S41-S57. doi: 10.3233/JAD-161206.
Tauopathies include a variety of neurodegenerative diseases associated with the pathological aggregation of hyperphosphorylated tau, resulting in progressive cognitive decline and motor impairment. The underlying mechanism for motor deficits related to tauopathy is not yet fully understood. Here, we use a novel transgenic tau mouse line, Tau 58/4, with enhanced neuron-specific expression of P301S mutant tau to investigate the motor abnormalities in association with the peripheral nervous system. Using stationary beam, gait, and rotarod tests, motor deficits were found in Tau 58/4 mice already 3 months after birth, which deteriorated during aging. Hyperphosphorylated tau was detected in the cell bodies and axons of motor neurons. At the age of 9 and 12 months, significant denervation of the neuromuscular junction in the extensor digitorum longus muscle was observed in Tau 58/4 mice, compared to wild-type mice. Muscle hypotrophy was observed in Tau 58/4 mice at 9 and 12 months. Using electron microscopy, we observed ultrastructural changes in the sciatic nerve of 12-month-old Tau 58/4 mice indicative of the loss of large axonal fibers and hypomyelination (assessed by g-ratio). We conclude that the accumulated hyperphosphorylated tau in the axon terminals may induce dying-back axonal degeneration, myelin abnormalities, neuromuscular junction denervation, and muscular atrophy, which may be the mechanisms responsible for the deterioration of the motor function in Tau 58/4 mice. Tau 58/4 mice represent an interesting neuromuscular degeneration model, and the pathological mechanisms might be responsible for motor signs observed in some human tauopathies.
tau蛋白病包括多种与异常磷酸化tau蛋白的病理性聚集相关的神经退行性疾病,导致进行性认知衰退和运动障碍。与tau蛋白病相关的运动功能缺陷的潜在机制尚未完全明确。在此,我们使用一种新型转基因tau小鼠品系Tau 58/4,其神经元特异性表达的P301S突变型tau蛋白增强,以研究与周围神经系统相关的运动异常。通过固定光束、步态和转棒试验发现,Tau 58/4小鼠在出生后3个月就已出现运动功能缺陷,且随着年龄增长而恶化。在运动神经元的细胞体和轴突中检测到了异常磷酸化的tau蛋白。与野生型小鼠相比,在9个月和12个月大时,Tau 58/4小鼠的趾长伸肌神经肌肉接头出现了明显的去神经支配。在9个月和12个月大时,Tau 58/4小鼠出现了肌肉萎缩。通过电子显微镜,我们观察到12个月大的Tau 58/4小鼠坐骨神经的超微结构变化,表明存在大轴突纤维丢失和髓鞘形成不足(通过g比值评估)。我们得出结论,轴突终末中积累的异常磷酸化tau蛋白可能诱导轴突逆行性变性、髓鞘异常、神经肌肉接头去神经支配和肌肉萎缩,这些可能是导致Tau 58/4小鼠运动功能恶化的机制。Tau 58/4小鼠代表了一种有趣的神经肌肉变性模型,其病理机制可能与某些人类tau蛋白病中观察到的运动体征有关。